Neurology: Volume 83, Number 23, December 2, 2014
About this course
- Released: 12/02/2014
- Expires: 12/02/2017
SPORADIC LATE-ONSET NEMALINE MYOPATHY WITH MGUS: LONG-TERM FOLLOW-UP AFTER MELPHALAN AND SCT
LEARNING OBJECTIVES:
Upon completion of the article by Voermans et al, the participant should be able to:
- List the clinical features of sporadic late-onset nemaline myopathy (SLONM)
- Recognize that previous studies have reported the effective treatment of patients with SLONM associated with MGUS (SLONM-MGUS) with high-dose melphalan (HDM) followed by autologous stem cell transplantation (SCT)
- Discuss the results of this study assessing long-term follow-up of SLONM-MGUS after melphalan and SCT
CORE COMPETENCIES:
The article by Voermans et al covers the following core competency:
- Medical Knowledge
ONSET OF MULTIPLE SCLEROSIS BEFORE ADULTHOOD LEADS TO FAILURE OF AGE-EXPECTED BRAIN GROWTH
LEARNING OBJECTIVES:
Upon completion of the article by Aubert-Broche et al, the participant should be able to:
- Recognize that there is growing evidence that multiple sclerosis (MS) is characterized by a neurodegenerative component
- Recognize that previous studies have shown that patients with MS with disease onset prior to age 18 years have been shown to have reduced thalamic and brain volumes
- Discuss the results of this study comparing the growth trajectory of the brain and specific substructures in patients with MS onset prior to age 18 years to that of age-matched healthy participants
CORE COMPETENCIES:
The article by Aubert-Broche et al covers the following core competency:
- Medical Knowledge
AUTHOR DISCLOSURES:
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
